Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Synchronoss Showcases Expanded Personal Cloud Platform, Capsyl Momentum, and Previews New Offering at CES 2026
-
JFB Construction Announces Anticipated 2025 Revenues of $32 million
-
Gabelli Launches Sports-Focused ETF: GOLS – Gabelli Opportunities in Live and Sports
-
Apollo to Announce Fourth Quarter and Full Year 2025 Financial Results on February 9, 2026
-
Willis Lease Finance Corporation Establishes New Asset Management Entity, Willis Aviation Capital
-
Roper Technologies schedules fourth quarter 2025 financial results conference call
-
Icon Energy Corp. Announces Reverse Stock Split
-
Earth Science Tech, Inc. (ETST) Issues Directive Industry Classification Update to SIC 2834; Formally Identifies as Pharmaceutical Entity Since 2022
-
Terrestrial Energy Executes DOE Agreement for Project TETRA Under Advanced Reactor Pilot Program
-
Provident Bank Annual Economic Outlook Survey: Business Owners Shift from Passive Optimism in 2025 to Active Investment in 2026
-
SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
XBP Global Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Biolojic Design Appoints Roger Waltzman as Chief Medical Officer
-
Magnite and Cognitiv Announce Deep Learning Integration for Real-Time Curation
-
Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026
-
CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter and Fiscal Year Ended December 31, 2025
-
Solid Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
nuVizz Advances Retail Last-Mile Delivery and Returns Excellence, Noted in the 2025 Gartner® Market Guide
-
Gentex to Highlight New Automotive Tech and Demonstrate Inroads Into New Markets at CES 2026
-
NuCana Appoints Theresa Bruce as Chief Operating Officer
-
Cadillac Escalade IQ Named 2026 MotorTrend SUV of the Year — Powered by Altia’s HMI Technology
-
Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Calvetti Ferguson Promotes Renato Antun to Tax Partner, Strengthening Nashville Market
-
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
-
Archrock Announces Private Offering of $500 Million of Senior Notes
-
Rail Vision Advances Indian Market Entry with Demonstration for Senior Governmental Officials from Multiple Government Departments
-
Centerra Gold Provides Notice of Fourth Quarter 2025 Results and Conference Call
-
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Nayax to Showcase New Digital Commerce Products for Specialty and Fashion Retail at NRF 2026
-
Rio Silver Highlights High-Grade Silver up to 6.26 g/t Au and 991 g/t Ag (28.9 oz per metric tonne) over 0.70 metres at Maria Norte and Advances a Clear Near-Term Development Path in Peru
-
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
-
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies
-
Silexion Therapeutics Releases CEO Letter to Shareholders Highlighting 2025’s Significant Achievements and Outlining Upcoming Milestones for 2026
-
SL Green and Rockpoint Announce Joint Venture for Ownership of 100 Park Avenue
-
PMGC Holdings Inc. Announces Strategic Share Acquisition in Micro Modular Reactor (MMR) Focused Nuclear Energy Company, Nuclea Energy Inc.
-
Centerra Gold Provides Notice of Fourth Quarter 2025 Results and Conference Call
-
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates v
-
Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities
-
Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program
-
Atsena Therapeutics Appoints McDavid Stilwell as Chief Financial Officer
-
Edible Garden Preliminary Holiday Sales Surge 26.4% Year-Over-Year During Key Time Period
-
BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer
-
Habit Brings Back Gotta Habit Meal Deals
-
Bread Financial Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call for Jan. 29
-
Reporting dates in 2026
-
Silexion Therapeutics Releases CEO Letter to Shareholders Highlighting 2025’s Significant Achievements and Outlining Upcoming Milestones for 2026
-
Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference
-
Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)
